Lectisol tablets 25 mg for skin inflammations and bacterial diseases (diaphenylsulfone, diaminodiphenyl sulfone, Dapsone, Aczone, antibiotic)
Product Code :
Availability : 8
General information on Japanese Lectisol tablets 25 mg for skin inflammations and bacterial diseases (diaphenylsulfone, diaminodiphenyl sulfone, Dapsone, Aczone, antibiotic)
Package details: 100 tablets
Manufacturer: Mitsubishi Tanabe Pharma Corporation, Japan
Active ingredients: diaphenylsulfone (chemical formula C12H12N2O2S)
Medical effect: Lectisol tablets are effective for the treatment of skin diseases accompanying blister or pustule and various bacterial diseases.
Contraindications and precautions: do not use for pregnant or breastfeeding women. If an allergic reaction occurs, stop using the medicine and consult with your doctor. If you’re taking any other medication or receiving any other treatment, you have to consult with your doctor before use.
Dosage and administration
For skin diseases: for adults, take 2-4 tablets a day, dividing into 2-3 times.
For bacterial infections: for adults, take 3-4 tablets a day. The doctor in charge may adjust the dosage according to patient’s disease, age and symptom.
How effective are Lectisol tablets 25 mg from Japan for skin inflammations and bacterial diseases (diaphenylsulfone, diaminodiphenyl sulfone, Dapsone, Aczone, antibiotic)?
Lectisol tablets contain diaphenylsulfone, an antibacterial and anti-inflammatory agent. It works by inhibiting production of activated oxygen causing inflammation and inhibiting bacterial synthesis of dihydrofolic acid, by this, suppressing proliferation of bacteria (S. Galijasevic. "The development of myeloperoxidase inhibitors". Bioorganic & Medicinal Chemistry Letters, 2019, 29 (1): 1–7).
Who should use Lectisol tablets 25 mg from Japan?
Lectisol tablets are used for the treatment of the following diseases and conditions:
- treatment of skin diseases accompanying blister or pustule, including acne and dermatitis herpetiformis,
- treatment of leprosy (together with rifampicin and clofazimine).
- treatment and prevention of various bacterial infections, including pneumocystis pneumonia and toxoplasmosis.